• Nem Talált Eredményt

1. Vinci Ld: Leonardo da Vinci on the human body: the anatomical, physiological, and embryological drawings of Leonardo da Vinci.: Charles Donald O'Malley, John Bertrand de Cusance Morant Saunders. H. Schuman, New York; 1952.

2. Macklem PT: A century of the mechanics of breathing. Am J Respir Crit Care Med 2004, 170(1):10-15.

3. Dixon WE: Contributions to the physiology of the lungs: Part I. The bronchial muscles, their innervation, and the action of drugs upon them. J Physiol 1903, 29(2):97-173.

4. Bayliss LE, Robertson GW: The visco-elastic properties of the lungs. Q J Exp Physiol Cogn Med Sci 1939, 29:27-47.

5. Dean Robert B: The kinetics of lung ventilation: An Evaluation of the Viscous and Elastic Resistance to Lung Ventilation with Particular Reference to the Effects of Turbulence and the Therapeutic Use of Helium. Am J Physiol 1941, 134(3):656-663.

6. Marshall R, Dubois AB: The measurement of the viscous resistance of the lung tissues in normal man. Clin Sci (Lond) 1956, 15(1):161-170.

7. Bachofen H: Lung tissue resistance and pulmonary hysteresis. J Appl Physiol 1968, 24(3):296-301.

8. Bachofen H, Duc G: Lung tissue resistance in healthy children. Pediatr Res 1968, 2(2):119-124.

9. Loring SH, Drazen JM, Smith JC, Hoppin FG, Jr.: Vagal stimulation and aerosol histamine increase hysteresis of lung recoil. J Appl Physiol 1981, 51(2):477-484.

10. Sasaki H, Takishima T, Nakamura M: Collateral resistance at alveolar level in excised dog lungs. J Appl Physiol 1980, 48(6):982-990.

11. Fredberg JJ, Keefe DH, Glass GM, Castile RG, Frantz ID, 3rd: Alveolar pressure nonhomogeneity during small-amplitude high-frequency oscillation. J Appl Physiol 1984, 57(3):788-800.

12. Bates JH, Abe T, Romero PV, Sato J: Measurement of alveolar pressure in closed-chest dogs during flow interruption. J Appl Physiol 1989, 67(1):488-492.

13. Bates JH, Lauzon AM, Dechman GS, Maksym GN, Schuessler TF: Temporal dynamics of pulmonary response to intravenous histamine in dogs: effects of dose and lung volume. J Appl Physiol 1994, 76(2):616-626.

14. Mishima M, Balassy Z, Bates JH: Acute pulmonary response to intravenous histamine using forced oscillations through alveolar capsules in dogs. J Appl Physiol 1994, 77(5):2140-2148.

15. Fredberg JJ, Ingram RH, Jr., Castile RG, Glass GM, Drazen JM: Nonhomogeneity of lung response to inhaled histamine assessed with alveolar capsules. J Appl Physiol 1985, 58(6):1914-1922.

99

16. Hantos Z, Petak F, Adamicza A, Daroczy B, Fredberg JJ: Differential responses of global airway, terminal airway, and tissue impedances to histamine. J Appl Physiol 1995, 79(5):1440-1448.

17. Ingenito EP, Davison B, Fredberg JJ: Tissue resistance in the guinea pig at baseline and during methacholine constriction. J Appl Physiol 1993, 75(6):2541-2548.

18. Ludwig MS, Dreshaj I, Solway J, Munoz A, Ingram RH, Jr.: Partitioning of pulmonary resistance during constriction in the dog: effects of volume history. J Appl Physiol 1987, 62(2):807-815.

19. Ludwig MS, Robatto FM, Sly PD, Browman M, Bates JH, Romero PV: Histamine-induced constriction of canine peripheral lung: an airway or tissue response? J Appl Physiol 1991, 71(1):287-293.

20. Nagase T, Moretto A, Ludwig MS: Airway and tissue behavior during induced constriction in rats: intravenous vs. aerosol administration. J Appl Physiol 1994, 76(2):830-838.

21. Petak F, Hantos Z, Adamicza A, Daroczy B: Partitioning of pulmonary impedance:

modeling vs. alveolar capsule approach. J Appl Physiol 1993, 75(2):513-521.

22. Vettermann J, Warner DO, Brichant JF, Rehder K: Halothane decreases both tissue and airway resistances in excised canine lungs. J Appl Physiol 1989, 66(6):2698-2703.

23. Petak F, Hantos Z, Adamicza A, Asztalos T, Sly PD: Methacholine-induced bronchoconstriction in rats: effects of intravenous vs. aerosol delivery. J Appl Physiol 1997, 82(5):1479-1487.

24. Lutchen KR, Suki B, Zhang Q, Petak F, Daroczy B, Hantos Z: Airway and tissue mechanics during physiological breathing and bronchoconstriction in dogs. J Appl Physiol 1994, 77(1):373-385.

25. Lutchen KR, Hantos Z, Petak F, Adamicza A, Suki B: Airway inhomogeneities contribute to apparent lung tissue mechanics during constriction. J Appl Physiol 1996, 80(5):1841-1849.

26. Otis DR, Jr., Petak F, Hantos Z, Fredberg JJ, Kamm RD: Airway closure and reopening assessed by the alveolar capsule oscillation technique. J Appl Physiol 1996, 80(6):2077-2084.

27. Hantos Z, Daroczy B, Csendes T, Suki B, Nagy S: Modeling of low-frequency pulmonary impedance in dogs. J Appl Physiol 1990, 68(3):849-860.

28. Hantos Z, Daroczy B, Suki B, Nagy S, Fredberg JJ: Input impedance and peripheral inhomogeneity of dog lungs. J Appl Physiol 1992, 72(1):168-178.

29. Babik B, Csorba Z, Czovek D, Mayr PN, Bogats G, Petak F: Effects of respiratory mechanics on the capnogram phases: importance of dynamic compliance of the respiratory system. Crit Care 2012, 16(5):R177.

30. Babik B, Asztalos T, Petak F, Deak ZI, Hantos Z: Changes in respiratory mechanics during cardiac surgery. Anesth Analg 2003, 96(5):1280-1287, table of contents.

31. Habre W, Schutz N, Pellegrini M, Beghetti M, Sly PD, Hantos Z, Petak F:

Preoperative pulmonary hemodynamics determines changes in airway and tissue

100

mechanics following surgical repair of congenital heart diseases. Pediatr Pulmonol 2004, 38(6):470-476.

32. Petak F, Babik B, Asztalos T, Hall GL, Deak ZI, Sly PD, Hantos Z: Airway and tissue mechanics in anesthetized paralyzed children. Pediatr Pulmonol 2003, 35(3):169-176.

33. von Ungern-Sternberg BS, Petak F, Hantos Z, Habre W: Changes in functional residual capacity and lung mechanics during surgical repair of congenital heart diseases: effects of preoperative pulmonary hemodynamics. Anesthesiology 2009, 110(6):1348-1355.

34. von Ungern-Sternberg BS, Petak F, Saudan S, Pellegrini M, Erb TO, Habre W: Effect of cardiopulmonary bypass and aortic clamping on functional residual capacity and ventilation distribution in children. J Thorac Cardiovasc Surg 2007, 134(5):1193-1198.

35. von Ungern-Sternberg BS, Saudan S, Petak F, Hantos Z, Habre W: Desflurane but not sevoflurane impairs airway and respiratory tissue mechanics in children with susceptible airways. Anesthesiology 2008, 108(2):216-224.

36. Petak F, Hayden MJ, Hantos Z, Sly PD: Volume dependence of respiratory impedance in infants. Am J Respir Crit Care Med 1997, 156(4 Pt 1):1172-1177.

37. Sly PD, Hayden MJ, Petak F, Hantos Z: Measurement of low-frequency respiratory impedance in infants. Am J Respir Crit Care Med 1996, 154(1):161-166.

38. www.who.int/gard/publications/chronic_respiratory_diseases.pdf

39. Gal TJ: Pulmonary mechanics in normal subjects following endotracheal intubation.

Anesthesiology 1980, 52(1):27-35.

40. Hatton KW, McLarney JT, Pittman T, Fahy BG: Vagal nerve stimulation: overview and implications for anesthesiologists. Anesth Analg 2006, 103(5):1241-1249.

41. Naguib M, Samarkandi AH, Bakhamees HS, Magboul MA, el-Bakry AK: Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine. Br J Anaesth 1995, 75(5):588-592.

42. North FC, Kettelkamp N, Hirshman CA: Comparison of cutaneous and in vitro histamine release by muscle relaxants. Anesthesiology 1987, 66(4):543-546.

43. Nagase T, Moretto A, Dallaire MJ, Eidelman DH, Martin JG, Ludwig MS: Airway and tissue responses to antigen challenge in sensitized brown Norway rats. Am J Respir Crit Care Med 1994, 150(1):218-226.

44. Habre W, Petak F: Anaesthesia management of patients with airway susceptibilities:

what have we learnt from animal models? Eur J Anaesth 2013, 30(9):519-528.

45. Albu G, Wallin M, Hallback M, Emtell P, Wolf A, Lonnqvist PA, Gothberg S, Petak F, Habre W: Comparison of static end-expiratory and effective lung volumes for gas exchange in healthy and surfactant-depleted lungs. Anesthesiology 2013, 119(1):101-110.

46. Lele E, Petak F, Carnesecchi S, Virag K, Argiroffo CB, Habre W: The protective effects of volatile anesthestics against the bronchoconstriction induced by an allergic reaction in sensitized rabbit pups. Anesth Analg 2013, 116(6):1257-1264.

101

47. Behrakis PK, Higgs BD, Baydur A, Zin WA, Milic-Emili J: Respiratory mechanics during halothane anesthesia and anesthesia-paralysis in humans. J Appl Physiol 1983, 55(4):1085-1092.

48. Brown RH, Zerhouni EA, Hirshman CA: Comparison of low concentrations of halothane and isoflurane as bronchodilators. Anesthesiology 1993, 78(6):1097-1101.

49. Habre W, Wildhaber JH, Sly PD: Prevention of methacholine-induced changes in respiratory mechanics in piglets: a comparison of sevoflurane and halothane.

Anesthesiology 1997, 87(3):585-590.

50. Hirshman CA, Bergman NA: Halothane and enflurane protect against bronchospasm in an asthma dog model. Anesth Analg 1978, 57(6):629-633.

51. Rooke GA, Choi JH, Bishop MJ: The effect of isoflurane, halothane, sevoflurane, and thiopental/nitrous oxide on respiratory system resistance after tracheal intubation.

Anesthesiology 1997, 86(6):1294-1299.

52. Sato J, Shinozuka N, Kochi A, Uchida H, Mizuguchi T: Low-dose halothane produces airway dilatation but does not alter parenchymal mechanics in the normal canine lung.

Can J Anaesth 1995, 42(5 Pt 1):438-445.

53. Goff MJ, Arain SR, Ficke DJ, Uhrich TD, Ebert TJ: Absence of bronchodilation during desflurane anesthesia: a comparison to sevoflurane and thiopental.

Anesthesiology 2000, 93(2):404-408.

54. Park KW, Dai HB, Lowenstein E, Sellke FW: Epithelial dependence of the bronchodilatory effect of sevoflurane and desflurane in rat distal bronchi. Anesth Analg 1998, 86(3):646-651.

55. Katoh T, Ikeda K: A comparison of sevoflurane with halothane, enflurane, and isoflurane on bronchoconstriction caused by histamine. Can J Anaesth 1994, 41(12):1214-1219.

56. Warner DO, Vettermann J, Brusasco V, Rehder K: Pulmonary resistance during halothane anesthesia is not determined only by airway caliber. Anesthesiology 1989, 70(3):453-460.

57. Jooste E, Zhang Y, Emala CW: Neuromuscular blocking agents' differential bronchoconstrictive potential in Guinea pig airways. Anesthesiology 2007, 106(4):763-772.

58. Peters JP, Barr DP: Studies on the respiratory mechanism in cardic dyspnea II. A note on the effective lung volume in cardiac dyspnea. Am J physiol 1920:335-344.

59. Peabody FW, Wentworth JA: Clinical studies of the respiration IV. The vital capacity of the lung and its relation to dyspnea. Arch Intern Med 1917, 20:483-498.

60. von Basch E: Ueber cardiale dyspnoe. Verhandl Congr Inn Med 1889, 8:384-395.

61. Frank NR, Lyons HA, Siebens AA, Nealon TF: Pulmonary compliance in patients with cardiac disease. Am J Med 1957, 22(4):516-523.

62. Lanteri CJ, Kano S, Duncan AW, Sly PD: Changes in respiratory mechanics in children undergoing cardiopulmonary bypass. Am J Respir Crit Care Med 1995, 152(6 Pt 1):1893-1900.

102

63. Bancalari E, Jesse MJ, Gelband H, Garcia O: Lung mechanics in congenital heart disease with increased and decreased pulmonary blood flow. J Pediatr 1977, 90(2):192-195.

64. Petak F, Habre W, Hantos Z, Sly PD, Morel DR: Effects of pulmonary vascular pressures and flow on airway and parenchymal mechanics in isolated rat lungs. J Appl Physiol 2002, 92(1):169-178.

65. Uhlig T, Wildhaber JH, Carroll N, Turner DJ, Gray PR, Dore N, James AL, Sly PD:

Pulmonary vascular congestion selectively potentiates airway responsiveness in piglets. Am J Respir Crit Care Med 2000, 161(4 Pt 1):1306-1313.

66. Baraldi E, Filippone M, Milanesi O, Magagnin G, Vencato F, Barbieri P, Pellegrino PA, Zacchello F: Respiratory mechanics in infants and young children before and after repair of left-to-right shunts. Pediatr Res 1993, 34(3):329-333.

67. Howlett G: Lung mechanics in normal infants and infants with congenital heart disease. Arch Dis Child 1972, 47(255):707-715.

68. von Basch S: Ueber cardiale dyspnoe. Verhandl Congr Inn Med 1889, 8:384-395.

69. Mitzner W, Lee W, Georgakopoulos D, Wagner E: Angiogenesis in the mouse lung.

Am J Pathol 2000, 157(1):93-101.

70. Tremblay LN, Yamashiro T, DeCampos KN, Mestrinho BV, Slutsky AS, Todd TR, Keshavjee SH: Effect of hypotension preceding death on the function of lungs from donors with nonbeating hearts. J Heart Lung Transplant 1996, 15(3):260-268.

71. Lubica H: Pathologic lung function in children and adolescents with congenital heart defects. Pediatr Cardiol 1996, 17(5):314-315.

72. Sheller JR: Regulation of the airway caliber. In: Pulmonary biology in health and disease. Edited by Bittar EE: Springer; 2002: 64-74.

73. Qian SY, Mitzner W: In vivo and in vitro lung reactivity in elastase-induced emphysema in hamsters. Am Rev Respir Dis 1989, 140(6):1549-1555.

74. Sterk PJ: The place of airway hyperresponsiveness in the asthma phenotype. Clin Exp Allergy 1995, 25 Suppl 2:8-11; discussion 17-18.

75. Habre W, Adamicza A, Lele E, Novak T, Sly PD, Petak F: The involvement of histaminic and muscarinic receptors in the bronchoconstriction induced by myorelaxant administration in sensitized rabbits. Anesth Analg 2008, 107(6):1899-1906.

76. Olsen PC, Ferreira TP, Serra MF, Farias-Filho FA, Fonseca BP, Viola JP, Cordeiro RS, Silva PM, Costa JC, Martins MA: Lidocaine-derivative JMF2-1 prevents ovalbumin-induced airway inflammation by regulating the function and survival of T cells. Clin Exp Allergy 2011, 41(2):250-259.

77. Myers CF, Fontao F, Janosi TZ, Boda K, Petak F, Habre W: Sevoflurane and desflurane protect cholinergic-induced bronchoconstriction of hyperreactive airways in rabbits. Can J Anaesth 2011, 58(11):1007-1015.

78. Zhou J, Iwasaki S, Watanabe A, Yamakage M: Synergic bronchodilator effects of a phosphodiesterase 3 inhibitor olprinone with a volatile anaesthetic sevoflurane in ovalbumin-sensitised guinea pigs. Eur J Anaesthesiol 2011, 28(7):519-524.

103

79. Yamakage M, Iwasaki S, Satoh JI, Namiki A: Inhibitory effects of the alpha-2 adrenergic agonists clonidine and dexmedetomidine on enhanced airway tone in ovalbumin-sensitized guinea pigs. Eur J Anaesthesiol 2008, 25(1):67-71.

80. Iwasaki S, Yamakage M, Satoh J, Namiki A: Different inhibitory effects of sevoflurane on hyperreactive airway smooth muscle contractility in ovalbumin-sensitized and chronic cigarette-smoking guinea pig models. Anesthesiology 2006, 105(4):753-763.

81. Burburan SM, Xisto DG, Ferreira HC, Riva Ddos R, Carvalho GM, Zin WA, Rocco PR: Lung mechanics and histology during sevoflurane anesthesia in a model of chronic allergic asthma. Anesth Analg 2007, 104(3):631-637.

82. Dewachter P, Jouan-Hureaux V, Lartaud I, Bello G, de Talance N, Longrois D, Mertes PM: Comparison of arginine vasopressin, terlipressin, or epinephrine to correct hypotension in a model of anaphylactic shock in anesthetized brown Norway rats.

Anesthesiology 2006, 104(4):734-741.

83. Zhang W, Shibamoto T, Kuda Y, Ohmukai C, Kurata Y: Pulmonary vasoconstrictive and bronchoconstrictive responses to anaphylaxis are weakened via beta2-adrenoceptor activation by endogenous epinephrine in anesthetized rats.

Anesthesiology 2011, 114(3):614-623.

84. Burka JF, Saad MH: Bronchodilator-mediated relaxation of normal and ovalbumin-sensitized guinea-pig airways: lack of correlation with lung adenylate cyclase activation. Br J Pharmacol 1984, 83(3):645-655.

85. Nishioka K, Shibata O, Yamaguchi M, Makita T, Sumikawa K: The effects of fentanyl on the contractile response of ovalbumin-sensitized rat trachea. Anesth Analg 2007, 104(5):1103-1108, tables of contents.

86. Bagcivan I, Cevit O, Yildirim MK, Gursoy S, Yildirim S, Kaya T, Mimaroglu C:

Investigation of the relaxant effects of propofol on ovalbumin-induced asthma in guinea pigs. Eur J Anaesthesiol 2007, 24(9):796-802.

87. Yamaguchi M, Shibata O, Nishioka K, Makita T, Sumikawa K: Propofol attenuates ovalbumin-induced smooth muscle contraction of the sensitized rat trachea: inhibition of serotonergic and cholinergic signaling. Anesth Analg 2006, 103(3):594-600.

88. Muraki M, Iwanaga T, Haraguchi R, Kubo H, Tohda Y: Continued inhalation of lidocaine suppresses antigen-induced airway hyperreactivity and airway inflammation in ovalbumin-sensitized guinea pigs. Int Immunopharmacol 2008, 8(5):725-731.

89. Serra MF, Anjos-Valotta EA, Olsen PC, Couto GC, Jurgilas PB, Cotias AC, Pao CR, Ferreira TP, Arantes AC, Pires AL et al: Nebulized Lidocaine Prevents Airway Inflammation, Peribronchial Fibrosis, and Mucus Production in a Murine Model of Asthma. Anesthesiology 2012.

90. Hirshman CA, Downes H, Farbood A, Bergman NA: Ketamine block of bronchospasm in experimental canine asthma. Br J Anaesth 1979, 51(8):713-718.

91. Mitsuhata H, Saitoh J, Shimizu R, Takeuchi H, Hasome N, Horiguchi Y: Sevoflurane and isoflurane protect against bronchospasm in dogs. Anesthesiology 1994, 81(5):1230-1234.

104

92. Misawa M, Sato J, Furukawa Y, Chiba Y, Hosokawa T: Abnormal modulation of cholinergic neurotransmission by opioid in hyperresponsive bronchus of rats. Gen Pharmacol 1996, 27(3):441-444.

93. Downes H, Hirshman CA: Lidocaine aerosols do not prevent allergic bronchoconstriction. Anesth Analg 1981, 60(1):28-32.

94. Downes H, Gerber N, Hirshman CA: I.V. lignocaine in reflex and allergic bronchoconstriction. Br J Anaesth 1980, 52(9):873-878.

95. Lambert AL, Winsett DW, Costa DL, Selgrade MK, Gilmour MI: Transfer of allergic airway responses with serum and lymphocytes from rats sensitized to dust mite. Am J Respir Crit Care Med 1998, 157(6 Pt 1):1991-1999.

96. Malherbe DC, Erpenbeck VJ, Abraham SN, Crouch EC, Hohlfeld JM, Wright JR:

Surfactant protein D decreases pollen-induced IgE-dependent mast cell degranulation.

Am J Physiol Lung Cell Mol Physiol 2005, 289(5):L856-866.

97. Layachi S, Rogerieux F, Robidel F, Lacroix G, Bayat S: Effect of combined nitrogen dioxide and carbon nanoparticle exposure on lung function during ovalbumin sensitization in Brown Norway rat. PLoS One 2012, 7(9):e45687.

98. Pappas RS: Toxic elements in tobacco and in cigarette smoke: inflammation and sensitization. Metallomics, 3(11):1181-1198.

99. Raeburn D, Webber SE: Proinflammatory potential of the airway epithelium in bronchial asthma. Eur Respir J 1994, 7(12):2226-2233.

100. Fireman P: Understanding asthma pathophysiology. Allergy Asthma Proc 2003, 24(2):79-83.

101. Hamid Q, Tulic MK, Liu MC, Moqbel R: Inflammatory cells in asthma: mechanisms and implications for therapy. J Allergy Clin Immunol 2003, 111(1 Suppl):S5-S12;

discussion S12-17.

102. Barnes NC, Piper PJ, Costello JF: Comparative actions of inhaled leukotriene C4, leukotriene D4 and histamine in normal human subjects. Thorax 1984, 39:500-504.

103. Bates JH, Rincon M, Irvin CG: Animal models of asthma. Am J Physiol Lung Cell Mol Physiol 2009, 297(3):L401-410.

104. Seibert AF, Allison RC, Bryars CH, Kirkpatrick MB: Normal airway responsiveness to methacholine in cardiac asthma. Am Rev Respir Dis 1989, 140(6):1805-1806.

105. Cosby RS, Stowell EC, Jr., Hartwig WR, Mayo M: Pulmonary function in left ventricular failure, including cardiac asthma. Circulation 1957, 15(4):492-501.

106. Kannel WB, Hubert H, Lew EA: Vital capacity as a predictor of cardiovascular disease: the Framingham study. Am Heart J 1983, 105(2):311-315.

107. Weiss ST: Pulmonary function as a phenotype physiologic marker of cardiovascular morbidity and mortality. Chest 1991, 99(2):265-266.

108. Friedman GD, Klatsky AL, Siegelaub AB: Lung function and outcome of myocardial infarction. N Engl J Med 1976, 295(23):1323.

109. Friedman GD, Klatsky AL, Siegelaub AB: Lung function and risk of myocardial infarction and sudden cardiac death. N Engl J Med 1976, 294(20):1071-1075.

105

110. Ishii M, Matsumoto N, Fuyuki T, Hida W, Ichinose M, Inoue H, Takishima T: Effects of hemodynamic edema formation on peripheral vs. central airway mechanics. J Appl Physiol 1985, 59(5):1578-1584.

111. Petak F, Babik B, Hantos Z, Morel DR, Pache JC, Biton C, Suki B, Habre W: Impact of microvascular circulation on peripheral lung stability. Am J Physiol Lung Cell Mol Physiol 2004, 287(4):L879-889.

112. Cabanes LR, Weber SN, Matran R, Regnard J, Richard MO, Degeorges ME, Lockhart A: Bronchial hyperresponsiveness to methacholine in patients with impaired left ventricular function. N Engl J Med 1989, 320(20):1317-1322.

113. Lockhart A, Dinh-Xuan AT, Regnard J, Cabanes L, Matran R: Effect of airway blood flow on airflow. Am Rev Respir Dis 1992, 146(5 Pt 2):S19-23.

114. Rolla G, Bucca C, Caria E, Scappaticci E, Baldi S: Bronchial responsiveness in patients with mitral valve disease. Eur Respir J 1990, 3(2):127-131.

115. Wiggs BR, Bosken C, Pare PD, James A, Hogg JC: A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992, 145(6):1251-1258.

116. Russell JA, Lai-Fook SJ: Reflex bronchoconstriction induced by capsaicin in the dog.

J Appl Physiol 1979, 47(5):961-967.

117. Roberts AM, Bhattacharya J, Schultz HD, Coleridge HM, Coleridge JC: Stimulation of pulmonary vagal afferent C-fibers by lung edema in dogs. Circ Res 1986, 58(4):512-522.

118. Keith IM: The role of endogenous lung neuropeptides in regulation of the pulmonary circulation. Physiol Res 2000, 49(5):519-537.

119. Adamicza A, Petak F, Asztalos T, Hantos Z: Effects of endothelin-1 on airway and parenchymal mechanics in guinea-pigs. Eur Respir J 1999, 13(4):767-774.

120. Adamicza A, Petak F, Asztalos T, Tiszlavicz L, Boros M, Hantos Z: Endothelin-1-induced airway and parenchymal mechanical responses in guinea-pigs: the roles of ETA and ETB receptors. Eur Respir J 2001, 17(5):975-981.

121. Habre W, Petak F, Ruchonnet-Metrailler I, Donati Y, Tolsa JF, Lele E, Albu G, Beghetti M, Barazzone-Argiroffo C: The role of endothelin-1 in hyperoxia-induced lung injury in mice. Respir Res 2006, 7:45.

122. Albu G, Petak F, Fontao F, Biton C, Pache JC, Habre W: Mechanisms of airway hyper-responsiveness after coronary ischemia. Respir Physiol Neurobiol 2008, 162(3):176-183.

123. Habre W, Albu G, Janosi TZ, Fontao F, von Ungern-Sternberg BS, Beghetti M, Petak F: Prevention of bronchial hyperreactivity in a rat model of precapillary pulmonary hypertension. Respir Res 2011, 12:58.

124. Petak F, Albu G, Lele E, Beghetti M, Habre W: Prevention of airway hyperresponsiveness induced by left ventricular dysfunction in rats. Respir Res 2012, 13:114.

106

125. von Ungern-Sternberg BS, Habre W, Regli A, Pache JC, Fontao F, Janosi TZ, Beghetti M, Petak F: Precapillary pulmonary hypertension leads to reversible bronchial hyperreactivity in rats. Exp Lung Res 2010, 36(3):129-139.

126. Czovek D, Novak Z, Somlai C, Asztalos T, Tiszlavicz L, Bozoki Z, Ajtai T, Utry N, Filep A, Bari F et al: Respiratory consequences of red sludge dust inhalation in rats.

Toxicol Lett 2012, 209(2):113-120.

127. Habre W, Janosi TZ, Fontao F, Meyers C, Albu G, Pache JC, Petak F: Mechanisms for lung function impairment and airway hyperresponsiveness following chronic hypoxia in rats. Am J Physiol Lung Cell Mol Physiol 2010, 298(4):L607-614.

128. Novak Z, Petak F, Banfi A, Toth-Szuki V, Barati L, Kosa L, Bari F, Szekely E: An improved technique for repeated bronchoalveolar lavage and lung mechanics measurements in individual rats. Respir Physiol Neurobiol 2006, 154(3):467-477.

129. Petak F, Hall GL, Sly PD: Repeated measurements of airway and parenchymal mechanics in rats by using low-frequency oscillations. J Appl Physiol 1998, 84(5):1680-1686.

130. Petak F, Wale JL, Sly PD: Effects of salbutamol and Ro-20-1724 on airway and parenchymal mechanics in rats. J Appl Physiol 1999, 87(4):1373-1380.

131. Hall GL, Petak F, McMenamin C, Sly PD: The route of antigen delivery determines the airway and lung tissue mechanical responses in allergic rats. Clin Exp Allergy 1999, 29(4):562-568.

132. Petak F, Banfi A, Toth-Szuki V, Barati L, Bari F, Szekely E, Novak Z: Airway responsiveness and bronchoalveolar lavage fluid profiling in individual rats: effects of different ovalbumin exposures. Respir Physiol Neurobiol 2010, 170(1):76-82.

133. Angelakos ET, Loew ER: Histamine toxicity in mice and rats following treatment with histaminase inhibitors. J Pharmacol Exp Ther 1957, 119(3):444-451.

134. Lulich KM, Paterson JW: An in vitro study of various drugs on central and peripheral airways of the rat: a comparison with human airways. Br J Pharmacol 1980, bronchoconstriction in sensitized guinea pigs: efficacy of common prophylactic drugs.

Respir Physiol Neurobiol 2004, 141(2):167-178.

137. Bayat S, Strengell S, Porra L, Janosi TZ, Petak F, Suhonen H, Suortti P, Hantos Z, Sovijarvi AR, Habre W: Methacholine and ovalbumin challenges assessed by forced oscillations and synchrotron lung imaging. Am J Respir Crit Care Med 2009, 180(4):296-303.

138. Habre W, Babik B, Chalier M, Petak F: Role of endogenous histamine in altered lung mechanics in rabbits. Anesthesiology 2002, 96(2):409-415.

139. Habre W, Scalfaro P, Schutz N, Stucki P, Petak F: Measuring end-expiratory lung volume and pulmonary mechanics to detect early lung function impairment in rabbits.

Respir Physiol Neurobiol 2006, 152(1):72-82.

107

140. Petak F, Hantos Z, Adamicza A, Gality H, Habre W: Development of bronchoconstriction after administration of muscle relaxants in rabbits with normal or hyperreactive airways. Anesth Analg 2006, 103(1):103-109, table of contents.

141. Albu G, Habre W, Fontao F, Morel DR, Petak F: The contribution of the pulmonary microvascular pressure in the maintenance of an open lung during mechanical ventilation. Respir Physiol Neurobiol 2007, 157(2-3):262-269.

142. Petak F, Albu G, Lele E, Hantos Z, Morel DR, Fontao F, Habre W: Lung mechanical and vascular changes during positive- and negative-pressure lung inflations:

importance of reference pressures in the pulmonary vasculature. J Appl Physiol 2009, 106(3):935-942.

143. Petak F, Janosi TZ, Myers C, Fontao F, Habre W: Impact of elevated pulmonary blood flow and capillary pressure on lung responsiveness. J Appl Physiol 2009, 107(3):780-786.

144. Lele E, Petak F, Fontao F, Morel DR, Habre W: Protective effects of volatile agents against acetylcholine-induced bronchoconstriction in isolated perfused rat lungs. Acta Anaesthesiol Scand 2006, 50(9):1145-1151.

145. Petak F, Habre W, Donati YR, Hantos Z, Barazzone-Argiroffo C: Hyperoxia-induced changes in mouse lung mechanics: forced oscillations vs. barometric

145. Petak F, Habre W, Donati YR, Hantos Z, Barazzone-Argiroffo C: Hyperoxia-induced changes in mouse lung mechanics: forced oscillations vs. barometric